A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH

Views
A ...1132

Total Visits Per Month

November 2023December 2023January 2024February 2024March 2024April 2024May 2024
A ...18203818141

File Visits

Views
29FL5e9GFDkgQ.pdf397